Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Steffens

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Urologie (Heidelberg, Germany)|April 19, 2024
[Urinary bladder tamponade-an urological emergency]Felix Steffens, Britta Grüne, Marie-Claire Rassweiler-Seyfried
Urologie (Heidelberg, Germany)|February 23, 2023
[Experiences from the commission of experts]Felix Steffens, Joachim Steffens, Jennifer Kranz, et al.
International Urology and Nephrology|January 27, 2025
Prognostic factors for overall survival in castration-resistant metastatic prostate cancer treated with docetaxel (MeProCSS): results from a German real-world cohortFelix Steffens, Frederik Wessels, Svetlana Hetjens, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Urologie (Heidelberg, Germany)|April 19, 2024
[Urinary bladder tamponade-an urological emergency]Felix Steffens, Britta Grüne, Marie-Claire Rassweiler-Seyfried
Urologie (Heidelberg, Germany)|February 23, 2023
[Experiences from the commission of experts]Felix Steffens, Joachim Steffens, Jennifer Kranz, et al.
International Urology and Nephrology|January 27, 2025
Prognostic factors for overall survival in castration-resistant metastatic prostate cancer treated with docetaxel (MeProCSS): results from a German real-world cohortFelix Steffens, Frederik Wessels, Svetlana Hetjens, et al.
Pageof 1